Takahiro Nishino

Takahiro Nishino

Auto-generated profile, based on publicly available information

Takahiro Nishino

Tokyo Metropolitan Research Institute for Environmental Protection, 1-7-5 Shinsuna, Koto, Tokyo, 136-0075, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Modern Rheumatology
Verified
Journal Article
Closed access
PDF file
TMToshihiro Matsui
Toshihiro Matsui
TYTomoya Yoshida
Tomoya Yoshida
TNTakahiro Nishino
Takahiro Nishino
SYShigeru Yoshizawa
Shigeru Yoshizawa
TSTetsuji Sawada
Tetsuji Sawada
STShigeto Tohma
Shigeto Tohma
Objectives: Our objective was to investigate trends in the treatment of patients with late-onset rheumatoid arthritis (LORA) using data from the National Database of Rheumatic Diseases in Japan (NinJa). Methods: Patients registered in the National Database of Rheumatic Diseases in Japan were classified according to the disease onset: at <65 years (young-onset rheumatoid arthritis); at 65–74 years (early LORA); and at ≥75 years (late LORA). Chronological changes in the treatment and disease activity were compared. Results: A total of 7178, 13,171, 15,295, and 15,943 patients were evaluated in 2010, 2013, 2016, and 2019, respectively. In all groups, the use of methotrexate gradually decreased, whereas that of biological/targeted synthetic disease-modifying antirheumatic drugs (DMARDs) increased; the use of tumor necrosis factor inhibitors decreased, whereas that of non-tumor necrosis factor inhibitors increased. LORA was characterized by more single DMARD use and less methotrexate and biological/targeted synthetic DMARD use. Tumor necrosis factor inhibitors and interleukin-6 inhibitors were used less frequently, whereas abatacept was utilized more frequently in late versus early LORA. Conventional synthetic DMARD (excluding methotrexate) and glucocorticoid use was higher in late versus early LORA. Conclusions: This analysis revealed chronological changes in the treatment of LORA in Japan. Differences between early and late LORA suggest that patients are not a homogeneous population.

22 August 2025 in Environmental Pollution
Verified
Journal Article
Closed access
STShusuke Takemine
Shusuke Takemine
SSSaki Shibamori
Saki Shibamori
KSKenshi Sankoda
Kenshi Sankoda
TNTakahiro Nishino
Takahiro Nishino
MMMamoru Motegi
Mamoru Motegi
IMIori Mishima
Iori Mishima

10 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
TNTakahiro Nishino
Takahiro Nishino
MKMika Kato
Mika Kato
YMYoshitaka Miyazawa
Yoshitaka Miyazawa
TTToshiki Tojo
Toshiki Tojo
DADaichi Asakawa
Daichi Asakawa
ASAtsushi Sawai
Atsushi Sawai
To assess the ecological risk of pharmaceuticals and personal care products (PPCPs) to the water environment of several cities in Japan, major local environmental research institutes, a private company, and an academic institution launched a joint research project in 2019. Under this initiative, local environmental research institutes surveyed the concentrations of 46 types of PPCPs at 59 points distributed across 15 cities in Japan. IDEA Consultants, Inc. calculated the unknown values of predicted no-effect concentration (PNEC) of six chemicals (telmisartan, candesartan, fexofenadine, diphenhydramine, diphenyl sulfone, and ketotifen) through bioassay experiments on aquatic organisms. Among the researched chemicals, the concentrations of clarithromycin, 14-hydroxyclarithromycin, erythromycin, diclofenac, carbamazepine, and telmisartan exceeded the PNEC in at least one sampling point. However, ozone treatment removed most of these chemicals, except for certain phosphate ester flame retardants. The mass balance of chemicals in the Tamagawa River flowing through Tokyo Prefecture was calculated by multiplying the concentration of each chemical with the flow rate at each sampling point in the river. The measured load of most chemicals at each sampling point of the Tamagawa River coincided to a certain extent with the cumulative load accumulated from the tributaries and sewage treatment plants to the uppermost point (Nagata Bridge). However, the measured load of diclofenac was significantly smaller than the estimated values at each sampling point, suggesting that diclofenac photodegrades while flowing down the river.

20 March 2022 in An Official Journal of the Japan Primary Care Association
Verified
Journal Article
Open access
PDF file
SASumiyo Akazawa
Sumiyo Akazawa
SMSeiko Miura
Seiko Miura
YNYasuhiro Nagayoshi
Yasuhiro Nagayoshi
JFJunya Fukushima
Junya Fukushima
TNTakahiro Nishino
Takahiro Nishino
SSShigeru Skamoto
Shigeru Skamoto
症例は77歳,男性.2年前からめまい・嚥下機能低下があり,むせ,血痰も伴い内科で精査が行われ,原因不明の嚥下機能低下による誤嚥性肺炎の入院歴がある.今回動悸・息切れを伴い近医受診した.心臓超音波検査では,左房内腫瘍が心拍動に伴って僧帽弁に嵌頓していた.当院心臓血管外科で緊急左房粘液腫摘出術,Patch Closureが施行された.摘出術後,嚥下機能が回復したことから術後Ortner症候群と診断された.嚥下機能低下,めまいの原因精査として心臓超音波検査が重要と考えられた一例を経験したので報告する.